Search this journal:     Advanced search
Original Research

Antimicrobial susceptibility profile of uropathogens in Maluti Adventist Hospital patients, 2011

Phillip Mubanga, Wilhelm J. Steinberg, Francois C. Van Rooyen

African Journal of Primary Health Care & Family Medicine; Vol 7, No 1 (2015), 5 pages. doi: 10.4102/phcfm.v7i1.800

Submitted: 25 November 2014
Published:  12 May 2015


Background: Urinary tract infections (UTIs) are amongst the most common infections encountered globally and are usually treated empirically based on bacterial resistance to antibiotics for a given region. Unfortunately in Lesotho, no published studies are available to guide doctors in the treatment of UTIs. Treatment protocols for Western countries have been adopted, which may not be applicable for this region.

Aim: To determine the antimicrobial susceptibility profile of uropathogens in outpatients at the Maluti Adventist Hospital.

Setting: The study was conducted at the outpatient department of the Maluti Adventist Hospital in Mapoteng, Lesotho.

Methods: This was a prospective cross-sectional study using consecutive sampling of patients with clinical symptoms of UTI. Midstream urine samples were screened through chemistry and microscopy, then positive urine samples were cultured. The isolated uropathogens underwent antimicrobial susceptibility testing and inclusion continued until 200 culture samples were obtained. Descriptive statistics were used in the data analysis.

Results: The top five cultured uropathogens were Escherichia coli (61.5%), Staphylococcus aureus (14%), Pseudomonasspecies (6.5%), Enterococcus faecalis (5.5%) and Streptococcus agalactiae (5%). The isolated uropathogens showed low sensitivity to cotrimoxazole (32.5% – 75.0%) and amoxicillin (33.2% – 87.5%) and high sensitivity to ciprofloxacin (84.0% – 95.1%) and nitrofurantoin (76.9% – 100%).

Conclusion: In the Maluti setting, cotrimoxazole and amoxicillin should be avoided as first-line drugs for the empirical treatment of community-acquired UTI. We recommend the use of nitrofurantoin as first choice.

Full Text:  |  HTML  |  EPUB  |  XML  |  PDF (301KB)

Author affiliations

Phillip Mubanga, Faculty of Health Sciences, Department of Family Medicine, University of the Free State, South Africa
Wilhelm J. Steinberg, Faculty of Health Sciences, Department of Family Medicine, University of the Free State, South Africa
Francois C. Van Rooyen, Faculty of Health Department Sciences, Department of Biostatistics, University of the Free State, South Africa



Total abstract views: 2331
Total article views: 3267


No related citations found

Comments on this article

Before posting your comment, please read our policy.
Post a Comment (Login required)

ISSN: 2071-2928 (print) | ISSN: 2071-2936 (online)

Connect on: Facebook, Twitter, Google+, LinkedIn and YouTube

Subscribe to our newsletter

All articles published in this journal are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license, unless otherwise stated.

Website design & content: ©2017 AOSIS (Pty) Ltd. All rights reserved. No unauthorised duplication allowed.

AOSIS Publishing | Empowering Africa through access to knowledge
Postnet Suite #110, Private Bag X19, Durbanville, South Africa, 7551
Tel: 086 1000 381 
Tel: +27 21 975 2602 
Fax: 086 5004 974

publishing(AT) replace (AT) with @

Please read the privacy statement.